|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0219 USD | +6.98% |
|
+14.06% | -64.33% |
| 06-02 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-15 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 4.47M 3.93M 3.65M 3.36M 6.3M 433M 6.41M 43.64M 17.02M 211M 16.77M 16.41M 732M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 6.19M 5.44M 5.05M 4.65M 8.72M 599M 8.87M 60.43M 23.57M 292M 23.22M 22.72M 1.01B | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | +6.98% | ||
| 1 week | +14.06% | ||
| Current month | -9.88% | ||
| 1 month | -2.67% | ||
| 3 months | -36.34% | ||
| 6 months | -50.23% | ||
| Current year | -64.33% |
| 1 week | 0.02 | 0.03 | |
| 1 month | 0.02 | 0.03 | |
| Current year | 0.02 | 0.1 | |
| 1 year | 0.02 | 0.1 | |
| 3 years | 0.02 | 0.1 | |
| 5 years | 0.02 | 0.36 | |
| 10 years | 0.02 | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/02/25 | Free | Chief Executive Officer | 3,000,000 | 1.6281% | ||
| 18/02/25 | Free | Chief Financial Officer | 2,350,000 | 1.2753% | ||
| 18/02/25 | Free | Director | 500,000 | 0.2714% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.98% | +14.06% | -44.84% | -55.58% | 4.18M | ||
| +1.97% | +2.53% | +52.73% | +156.66% | 1,037B | ||
| +1.42% | +4.96% | +54.39% | +52.34% | 615B | ||
| +1.43% | +5.25% | +37.31% | +78.74% | 448B | ||
| +5.14% | +5.84% | +37.54% | +27.28% | 326B | ||
| +1.85% | +4.64% | +38.53% | +39.87% | 293B | ||
| -0.11% | +0.97% | +22.57% | +17.81% | 264B | ||
| +0.25% | -3.10% | -24.44% | -42.25% | 216B | ||
| +1.49% | +3.68% | +21.53% | +58.21% | 198B | ||
| +0.40% | -0.64% | +18.78% | +62.28% | 162B | ||
| Average | +2.08% | +1.69% | +21.41% | +39.54% | 355.74B | |
| Weighted average by Cap. | +1.73% | +1.47% | +38.33% | +75.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.81M 12.83M 11.8M 22.13M 1.52B 22.53M 153M 59.85M 742M 58.96M 57.68M 2.57B | 13.79M 12.13M 11.27M 10.36M 19.43M 1.34B 19.78M 135M 52.55M 651M 51.77M 50.65M 2.26B |
| Net income | -2.39M -2.11M -1.96M -1.8M -3.37M -232M -3.43M -23.39M -9.12M -113M -8.99M -8.79M -392M | -958K -843K -783K -720K -1.35M -92.77M -1.37M -9.36M -3.65M -45.25M -3.6M -3.52M -157M |
| Net Debt | 325K 286K 266K 244K 458K 31.47M 466K 3.18M 1.24M 15.35M 1.22M 1.19M 53.26M | 1.72M 1.51M 1.4M 1.29M 2.42M 166M 2.46M 16.79M 6.55M 81.15M 6.45M 6.31M 282M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | $0.0219 | +6.98% | 497,296 |
| 22/07/26 | $0.0205 | +3.39% | 305,777 |
| 21/07/26 | $0.0198 | +10.00% | 525,767 |
| 20/07/26 | $0.0180 | -10.00% | 528,130 |
| 17/07/26 | $0.0200 | -2.44% | 1,039,549 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions

















